男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

AstraZeneca China signs major deal with UK company Medcity

By Liu Zhihua | chinadaily.com.cn | Updated: 2022-12-15 21:14
Share
Share - WeChat
Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. [Photo/Agencies]

AstraZeneca China signed a major collaboration agreement with the UK life and health sciences incubation platform MedCity on Thursday during the 2022 Beijing Intelligent Health Technology and Innovation Forum which was held online, a move to promote innovation exchange between Chinese and global healthcare industries.

Through this partnership, AstraZeneca's innovation hub iCampus will work together with MedCity and its industrial partners to strengthen interactions between local and overseas healthcare innovation ecosystems.

They aim to deepen cooperation on aspects including technology sourcing and transfer, capital financing and investment, and partnership network expansion.

AstraZeneca also entered a partnership with Israeli innovation incubator Trendlines at the forum. It will partner with Trendlines to promote the incubation of tech innovation firms and the commercialization of new technologies and therefore to fulfill the huge demand in the Chinese and global healthcare markets, leveraging on Trendlines' innovation strengths, research and development experience in the medical device industry and Israel's unique industrial incubation model and innovation capabilities, the company said.

In 2021, AstraZeneca's regional headquarters in northern China were officially inaugurated in Beijing, and the Beijing International Life Science Innovation Campus (Beijing iCampus) and the Community Intelligence Healthcare Innovation Center were also established in the city.

At the Forum, Beijing iCampus also welcomed a new round of five high-tech startups to its facilities. They will work together to integrate regional innovation ecosystem resources and empower the local smart healthcare industry.

Leon Wang, executive vice-president of AstraZeneca, and president of AstraZeneca China, said the company will leverage Beijing city's international industrial advantages to continue to expand its innovation ecosystem, enable the implementation of more innovative projects in the Chinese capital, and add momentum to the city's smart healthcare ecosystem. 

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 福建省| 政和县| 黄山市| 黑水县| 宝应县| 新民市| 武威市| 梅河口市| 黄平县| 乳山市| 大冶市| 格尔木市| 兴仁县| 女性| 铜鼓县| 出国| 麻江县| 遂宁市| 宝兴县| 林周县| 日土县| 咸阳市| 自治县| 乌什县| 北京市| 塔城市| 民勤县| 宜城市| 枣阳市| 通辽市| 卢龙县| 涞水县| 且末县| 瑞丽市| 桑植县| 利津县| 莱西市| 阿图什市| 蒙自县| 应城市| 新绛县|